Clinical trial

AngioJET Thrombectomy and STENTing for Treatment of Acute Myocardial Infarction

NCT00275990 · Boston Scientific Corporation, Industry · Completed

Key facts

NCT number NCT00275990
Title AngioJET Thrombectomy and STENTing for Treatment of Acute Myocardial Infarction
Official title AngioJET Rheolytic Thrombectomy Before Direct Infarct Artery STENTing in Patients Undergoing Primary PCI for Acute Myocardial Infarction: [JETSTENT] Study
Lead sponsor Boston Scientific Corporation, Industry
Status Completed
Phase Phase 4
Study type Interventional
Conditions Myocardial Infarction
Intervention type Device
Interventions rheolytic thrombectomy with direct stenting, direct stenting
Enrollment 501
Start date Dec 1, 2005
Primary completion Oct 1, 2009
Completion Aug 1, 2010
First posted Jan 12, 2006
Last update posted Oct 9, 2014
Countries Italy

At a glance

  • 1–9 Study sites
  • No Results posted
  • 1–9 Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies